When the average expression for each metastatic site was calculated, BCL2 expression was higher in AR-negative tumors, although this did not reach statistical significance (Mann-Whitney U test, P = 0.08) ( Figure 2I ).
← all excerpts
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity.
1
0.0800
0.0800